With the lessons learned that
(A.) I need to provide more detail, and be more patient with challenging questions and science
AND
(B) Posters cannot simply take copyrighted material,
let's keep this thread positive and on topic. The info is far too important to get lost in the dust.
Let me try to clarify the question of "Hand filled" vs "Commercial". I did a poor job of explaining this initially, and the chart is not clear. The commercial would be an example of a typical non-salt form RLA, polymerized to a degree by the processing/capping. The hand filled would be illustrative of a non stabilized but non-polymerized RLA, the Dex would be illustrative of a salt-form RLA (such as K-RALA powder).
da sense you make a great point in your post. You are absolutely correct that ALA is stable. And that is by virtue of the fact it is a racemic mixture. Until recently the only way to stabilize RLA was as ALA (containing SLA), or, as a salt-form: K-RALA.
(late edit) Yes da sense, you could take the ALA, but you have to take that much more of it to get the effective RLA portion AND in so doing subject your body's chiral receptors to the unnatural S enantiomer. Some believe this has the possibility, in worst case, actually damage those receptors.
The problem with this is that the stability was obtained as a "deal with the devil" - addition of excipient content (K-RALA, a lipoate form) or content un-natural to the body's receptors (SLA). The result is either lowered bioavailabiltiy of the RLA or severe peaking.
Peakiness- you max plasma levels in about 20-30 minutes, and drop back to baseline in about 1.5 hours. Peaking doses of RLA are not optimal to gaining the best effects of RLA. Some believe the sharp peaks may even tip the cells into a pro-oxidative state.
Duration of effect- think of any other substance you take for therapeutic effect, you usually want a nice long, flat curve of plasma level right? For example- an antibiotic.
Absolute values are not the issue here, the challenge is manifold:
1. Keep it stable in processing/capping. (polymerization issue #1)
2. Keep it stable in stomach acid. (polymerization issue #2)
3. Get rid of excipient content (who needs or wants that?)
4. Extend duration of effect. (optimization of plasma levels).
As of today, the ONLY solution to all the parts of the challenge is the MCT stabilized and transported RLA. This is the RALA-Gel (just RLA and D-Biotin) or Mito-GOLD (which adds R-Dihydro and Delta-Tocotrienol for a "beefed up" antioxidant action) products. The MCT stabilizes it, get the RLA to the entero-hepatic portal (adds the bioavailability factor), and also provides for the optimized plasma levels.
So... the tee-shirt should read: "Got MCT?"
)
This optimization is the real key and the true breakthrough, and indeed is the whole point of the chart. Shame on me for not understanding that I needed to detail this out.
There are 7 different pages of very detailed science
HERE. Yes, it is not easy, but once you think it through it is quite clear and makes perfect sense. Also keep in mind, this is research that has not been done by any other company. ALL sellers of ALA or RLA buy it from some supplier. GeroNova is the only USA manufacturer of RLA. As a manufacturer, you would expect them to have knowledge that bottlers do not.
Go easy on me folks, I am trying something on this forum never done before- acting as a conduit to provide realtime breakthroughs from a manufacturer. They invested time and money (and blood) to do this study. This stuff is usually kept undercover until released through official channels. GeroNova didn't have to make this chart available to me, nor did I have to make it available to you. By all means, be skeptical, but also understand this is just a peek behind the curtain, much more to come in the next weeks and months. If you think this is just marketing hype, I need to know, as this is a boatload of time and effort for me that I can spend in other ways.
Cheers,
Pete
Edited by psychenaut, 13 June 2005 - 09:28 PM.